20
Ctx Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CHLOROTHIAZIDE USP, with a corresponding US DMF Number 23015.
Remarkably, this DMF maintains an Active status since its submission on July 23, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 04, 2012, and payment made on February 07, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II